Grossi Federico 4
4 · Apellis Pharmaceuticals, Inc. · Filed Feb 16, 2022
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2022-02-15$45.43/sh−375$17,036→ 106,086 total
Footnotes (1)
- [F1]This is a scheduled sale from 10B5-1 trading plan.